Notable Developments Implantable Gastric Stimulation Market: Manufacturers Focus on Prominent Indications

The implantable gastric stimulation landscape has witnessed significant growth with the continual advancements in technology and healthcare, along with the expansion of healthcare IT. As patients are opting for incision-free medical therapies, there is an increasing adoption of implantable gastric stimulation devices. Implantable gastric stimulation therapy is emerging an effective procedure and a cost-effective alternative as stated by a research study that examined the outcome of the outcome of electronic implantable gastric stimulation devices.

Innovations Remain Key to Market Growth: Research Focused on Bringing Improvements

New developments and product innovations are significant growth driving factors for the implantable gastric stimulation landscape. For instance, IEEE published a journal that describes a configurable system designed by a team of skilled researchers that can acquire the gastric electrical activity through a wireless network and deliver high-energy electric stimulation to modulate its activity. This miniature system is claimed to be one of its kind and can be used for the treatment of gastrointestinal disorders.

Minimally Invasive Procedures Gain Momentum: Implantable Gastric Stimulation for Stomach Emptying Disorders

With the paradigm preference shift towards minimally invasive procedures, the use of implantable gastric stimulation has grown tremendously over time. For instance, the medical professionals at the Bariatric, Foregut, and Advanced Gastrointestinal Surgery Division of Stony Brook Medical Center implemented the first-ever revolutionary, minimally invasive procedure— POP (per-oral pyloromyotomy) for the treatment of gastroparesis conducted in the Suffolk County. This incision-free, minimally invasive procedure included the use of implantable gastric stimulation device—the gastric electric stimulator, placement of feeding tube, total gastrectomy, pyloroplasty, and the POP procedure.

Apart from stomach emptying disorder, implantable gastric stimulation therapy also plays a significant role in morbid obesity treatment. Various research activities are conducted to understand the efficacy of implantable gastric stimulation in battling obesity, which has stated the therapy to be a relatively less complex procedure than conventional bariatric operations.

Battling Obesity with Implantable Gastric Electric Stimulators

The demand for implantable gastric stimulators is expected to be influenced by factors such as the increasing prevalence of gastroparesis, the growth in minimally invasive procedures on the backdrop of significant developments in healthcare. The gastric electric stimulators landscape is expected to face major opportunities over time. Although gastric electric stimulators are finding major significance in the treatment and management of gastroparesis, there are other indications that are also gaining major vitality with time, which include obesity. Overweight and obesity are major risk factors for various chronic diseases including cancer, cardiovascular diseases, and diabetes and are on a dramatic rise across the globe. According to the WHO, the global prevalence of obesity has nearly tripled since 1975 until 2016. The gastric electric stimulators are gaining major popularity for being the most preferred treatment alternative for such difficult to treat disorders.

Key Developments

The dramatic prevalence of obesity is emerging as a critical concern worldwide. In light of these incidents, the companies operating in the gastric electric stimulators market are expanding their product portfolio to mitigate the risk of obesity and thereby strengthen their hold over the market. For instance, ReShape Lifesciences, a provider of minimally invasive medical devices for obesity and metabolic disease treatments recently stated that it received an Issue Notification for the patent that covers its gastric restriction device for treating obesity from the United States Patent and Trademark Office. This revolutionary device is claimed to be a novel and break-through advancement in the field of obesity which is implanted in a minimally invasive procedure that is designed to imitate the traditional bariatric surgery without permanent changes in anatomy, with an aim to control obesity and weight gain.

Download Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8992

FMI Blog

Leave a Reply

Your email address will not be published. Required fields are marked *